Patient Advocacy and Support

The Dawn of De-escalation: CompassHER2-pCR Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Treatment

• Patient Advocacy and Support

The Dawn of De-escalation: CompassHER2-pCR Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Treatment

Sagoh October 16, 2026

For decades, the standard of care for aggressive breast cancer followed a "more is better" philosophy. In...

Read More Read more about The Dawn of De-escalation: CompassHER2-pCR Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Treatment

Precision De-escalation: CompassHER2-pCR Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Treatment

• Patient Advocacy and Support

Precision De-escalation: CompassHER2-pCR Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Treatment

Asro October 16, 2026

For decades, the standard of care for aggressive breast cancer was defined by a "more is better"...

Read More Read more about Precision De-escalation: CompassHER2-pCR Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Treatment

Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Comprehensive Overview

• Patient Advocacy and Support

Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Comprehensive Overview

Nila Kartika Wati October 15, 2026

Introduction: A Growing Conversation In recent years, Glucagon-Like Peptide-1 (GLP-1) receptor agonists have surged into the medical...

Read More Read more about Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Comprehensive Overview

Global Landmarks to Glow in Teal, Green, and Pink: A Unified Stand Against Metastatic Breast Cancer

• Patient Advocacy and Support

Global Landmarks to Glow in Teal, Green, and Pink: A Unified Stand Against Metastatic Breast Cancer

Lina Irawan October 15, 2026

NEW YORK, NY — As the sun sets on October 13, 2026, the global skyline will undergo...

Read More Read more about Global Landmarks to Glow in Teal, Green, and Pink: A Unified Stand Against Metastatic Breast Cancer

Bridging the Atlantic: Breast Cancer Canada to Host Pivotal "Canadian Night" at ESMO 2026 in Madrid

• Patient Advocacy and Support

Bridging the Atlantic: Breast Cancer Canada to Host Pivotal "Canadian Night" at ESMO 2026 in Madrid

Lina Hope October 15, 2026

MADRID, SPAIN – As the global oncology community prepares to descend upon the Spanish capital for the...

Read More Read more about Bridging the Atlantic: Breast Cancer Canada to Host Pivotal "Canadian Night" at ESMO 2026 in Madrid

Navigating the Nexus: GLP-1 Medications and Breast Cancer – Emerging Insights and Crucial Conversations

• Patient Advocacy and Support

Navigating the Nexus: GLP-1 Medications and Breast Cancer – Emerging Insights and Crucial Conversations

Siti Muinah October 15, 2026

By Douglas Feil, Chief Program Officer, National Breast Cancer Foundation (NBCF) The landscape of medical treatment is...

Read More Read more about Navigating the Nexus: GLP-1 Medications and Breast Cancer – Emerging Insights and Crucial Conversations

Global Illumination: #LightUpMBC to Turn 325 Landmarks Teal, Green, and Pink to Fund Metastatic Breast Cancer Research

• Patient Advocacy and Support

Global Illumination: #LightUpMBC to Turn 325 Landmarks Teal, Green, and Pink to Fund Metastatic Breast Cancer Research

Siti Muinah October 15, 2026

NEW YORK, NY — As the world enters the second week of Breast Cancer Awareness Month, a...

Read More Read more about Global Illumination: #LightUpMBC to Turn 325 Landmarks Teal, Green, and Pink to Fund Metastatic Breast Cancer Research

The De-Escalation Revolution: CompassHER2-pCR Trial Signals a New Era in HER2-Positive Breast Cancer Treatment

• Patient Advocacy and Support

The De-Escalation Revolution: CompassHER2-pCR Trial Signals a New Era in HER2-Positive Breast Cancer Treatment

Iffa Jayyana October 15, 2026

In the evolving landscape of oncology, the traditional mantra of "more is better" is rapidly giving way...

Read More Read more about The De-Escalation Revolution: CompassHER2-pCR Trial Signals a New Era in HER2-Positive Breast Cancer Treatment

Canadian Night at ESMO 2026

• Patient Advocacy and Support

Canadian Night at ESMO 2026

Ali Ikhwan October 15, 2026

Scheduled for Saturday, October 24, 2026, the reception will be held at the prestigious Neptune Room within...

Read More Read more about Canadian Night at ESMO 2026

Navigating the Nexus: GLP-1 Medications and Breast Cancer – Emerging Insights and Patient Guidance

• Patient Advocacy and Support

Navigating the Nexus: GLP-1 Medications and Breast Cancer – Emerging Insights and Patient Guidance

Suro Senen October 15, 2026

By Douglas Feil, NBCF Chief Program Officer The landscape of medical treatment is constantly evolving, and in...

Read More Read more about Navigating the Nexus: GLP-1 Medications and Breast Cancer – Emerging Insights and Patient Guidance